Pressure Bio's Q2 Revenues Up 49 Percent on PCT Sales Jump | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that its second-quarter revenues rose 49 percent year over year as sales connected to its flagship technology increased 78 percent.

During the three months ended June 30, the South Easton, Mass.-based sample prep instrument firm posted revenues of $402,104, compared to $270,381 for Q2 2009. Sales of its pressure cycling technology, or PCT, instruments, and related products and services rose to $283,382 from $159,202 in Q2 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.